全文获取类型
收费全文 | 963篇 |
免费 | 178篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 2篇 |
妇产科学 | 8篇 |
基础医学 | 72篇 |
口腔科学 | 1篇 |
临床医学 | 21篇 |
内科学 | 33篇 |
皮肤病学 | 1篇 |
神经病学 | 10篇 |
特种医学 | 3篇 |
外科学 | 893篇 |
综合类 | 67篇 |
预防医学 | 4篇 |
眼科学 | 7篇 |
药学 | 19篇 |
中国医学 | 2篇 |
肿瘤学 | 12篇 |
出版年
2024年 | 1篇 |
2023年 | 12篇 |
2022年 | 5篇 |
2021年 | 20篇 |
2020年 | 37篇 |
2019年 | 40篇 |
2018年 | 39篇 |
2017年 | 36篇 |
2016年 | 37篇 |
2015年 | 57篇 |
2014年 | 51篇 |
2013年 | 57篇 |
2012年 | 39篇 |
2011年 | 44篇 |
2010年 | 57篇 |
2009年 | 38篇 |
2008年 | 43篇 |
2007年 | 62篇 |
2006年 | 53篇 |
2005年 | 51篇 |
2004年 | 76篇 |
2003年 | 67篇 |
2002年 | 42篇 |
2001年 | 43篇 |
2000年 | 34篇 |
1999年 | 35篇 |
1998年 | 17篇 |
1997年 | 13篇 |
1996年 | 24篇 |
1995年 | 11篇 |
1994年 | 8篇 |
1992年 | 4篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1986年 | 1篇 |
排序方式: 共有1157条查询结果,搜索用时 15 毫秒
71.
72.
目的 探讨链脲左菌素(STZ)建立BALB/c nu/nu裸鼠Ⅰ型糖尿病模型的方法,及将大鼠胰岛分离纯化后移植至糖尿病裸鼠皮下,对移植后裸鼠进行疗效评价。方法 选用Balb/c裸鼠分为三组:糖尿病且胰岛移植组、糖尿病胰岛未移植组和正常组;用STZ对裸鼠进行糖尿病建模,大鼠胰岛分离、纯化后移植至糖尿病裸鼠背部皮下,进行血糖、体重和HE染色考察,以糖尿病未移植组和正常组作对照。结果 STZ浓度175 mg/kg时,腹腔注射裸鼠糖尿病造模成功率高,纯化的大鼠胰岛活性较好,但移植后疗效平均维持时间约5 d,移植第5 d的OGTT结果显示胰岛皮下移植组和糖尿病组血糖均较正常组高,移植3 d时HE染色显示胰岛在皮下存活,但胰岛中心部位细胞有坏死。结论 本研究建立了一种免疫排斥缺陷宿主异种胰岛皮下移植治疗糖尿病的方法,为进一步探索改进胰岛移植研究提供参考。 相似文献
73.
Pre‐clinical heterotopic intrathoracic heart xenotransplantation: a possibly useful clinical technique 下载免费PDF全文
Bruno Reichart Stefan Buchholz Fabian Werner Isabelle Lutzmann Michael Schmoeckel Andreas Bauer Michael Thormann Martin Langenmayer Nadja Herbach Heike Pohla Rudolf Herzog Christopher G. A. McGregor David Ayares Eckhard Wolf Nikolai Klymiuk Andrea Baehr Alexander Kind Christian Hagl Ute Ganswindt Claus Belka Paolo Brenner 《Xenotransplantation》2015,22(6):427-442
74.
75.
K. F. E. Lee B. Lu J. C. Roussel L. J. Murray‐Segal E. J. Salvaris S. J. Hodgkinson B. M. Hall A. J. F. d'Apice H. Gock 《American journal of transplantation》2012,12(9):2363-2372
Thrombosis and inflammation are major obstacles to successful pig‐to‐human solid organ xenotransplantation. A potential solution is genetic modification of the donor pig to overexpress molecules such as the endothelial protein C receptor (EPCR), which has anticoagulant, anti‐inflammatory and cytoprotective signaling properties. Transgenic mice expressing human EPCR (hEPCR) were generated and characterized to test this approach. hEPCR was expressed widely and its compatibility with the mouse protein C pathway was evident from the anticoagulant phenotype of the transgenic mice, which exhibited a prolonged tail bleeding time and resistance to collagen‐induced thrombosis. hEPCR mice were protected in a model of warm renal ischemia reperfusion injury compared to wild type (WT) littermates (mean serum creatinine 39.0 ± 2.3 μmol/L vs. 78.5 ± 10.0 μmol/L, p < 0.05; mean injury score 31 ± 7% vs. 56 ± 5%, p < 0.05). Heterotopic cardiac xenografts from hEPCR mice showed a small but significant prolongation of survival in C6‐deficient PVG rat recipients compared to WT grafts (median graft survival 6 vs. 5 days, p < 0.05), with less hemorrhage and edema in rejected transgenic grafts. These data indicate that it is possible to overexpress EPCR at a sufficient level to provide protection against transplant‐related thrombotic and inflammatory injury, without detrimental effects in the donor animal. 相似文献
76.
Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade 总被引:1,自引:0,他引:1
Bühler L Deng S O'Neil J Kitamura H Koulmanda M Baldi A Rahier J Alwayn IP Appel JZ Awwad M Sachs DH Weir G Squifflet JP Cooper DK Morel P 《Xenotransplantation》2002,9(1):3-13
The aim of the present study was to assess the survival of adult porcine islets transplanted into baboons receiving either (I) conventional triple drug immunosuppressive therapy or (2) a non-myeloablative regimen and an anti-CD154 monoclonal antibody (mAb) aimed at tolerance-induction. Group 1 baboons (n = 3) were pancreatectomized prior to intraportal injection of 10,000 porcine islet equivalents (IE)/kg and immunosuppressed with anti-thymocyte globulin (ATG), cyclosporine and azathioprine. In Group 2 (n = 2), non-pancreatectomized baboons underwent induction therapy with whole body and thymic irradiation, and ATG. Extracorporeal immunoadsorption (EIA) of anti-Galalpha1,3Gal (Gal) antibody was carried out. Maintenance therapy was with cobra venom factor, cyclosporine. mycophenolate mofetil, methylprednisolone and anti-CD154 mAb. Porcine islets were injected intraportally (14,000 and 32,000 IE/kg, respectively) and high-dose pig mobilized peripheral blood progenitor cells (3 x 10(10) cells/kg) were infused into a systemic vein. Porcine islets were also implanted in the sternomastoid muscle to facilitate subsequent biopsies. In both groups. porcine C-peptide was measured, and histological examination of liver or sternomastoid muscle biopsies was performed at regular intervals. In Group 1, total pancreatectomy reduccd human C-peptide to < 0.1 ng/ml and induced insulin-requiring diabetes. The transplantation of porcine islets was followed by normalization of glycemia for 15-24 h. Porcine C-peptide was detected only transiently immediately after porcine islet injection (maximum 0.12 ng/ml). Histological examination of liver biopsies taken between days 2 and 19 did not reveal viable islets, but necrotic cell structures with mononuclear cell infiltrates were identified in portal venules. In Group 2, injection of porcine islets into non-pancreatectomized recipients induced a transient hypoglycemia (2-4 h) requiring concentrated intravenous dextrose administration. Porcine C-peptide was detectable for 5 and 3 days (maximum 2.8 and 1.0 ng/ml), respectively. Baboon #4 died on day 12 from small bowel intussusception. Liver and sternomastoid muscle biopsies showed well-preserved porcine islets, staining positive for insulin and glucacon, without signs of rejection. In baboon #5, viable islets were detected in the sternomastoid muscle biopsy on day 14, but not on day 28 or thereafter. A progressive mononuclear cell and macrophage infiltration was seen in the biopsies. In conclusion, conventional immunosuppression allowed survival of porcine islets in baboons for < 24 h. The non-myeloablative regimen prolonged survival of porcine islets for > 14 days. However, despite depletion of T cells, anti-Gal antibody and complement, and CD154-hlockade, porcine islets were rejected by day 28. These results suggest that powerful innate immune responses are involved in rejection of discordant xenogencic islets. 相似文献
77.
Denaro M Kolber-Simonds D Schad V Muthukumar S Germana S White-Scharf ME Banerjee PT LeGuern C Andersson G 《Xenotransplantation》2002,9(2):115-124
We recently established that molecular chimeras of major histocompatibility complex (MHC) class II molecules, created via retroviral transfer of allogeneic class II cDNAs into bone marrow cells (BMCs), alleviated complications associated with mixed BMC chimeras while leading to T cell tolerance to renal grafts sharing the transferred class II. Initially demonstrated for allogeneic transplants in miniature swine, this concept was extended to T-dependent antibody (Ab) responses to xenogeneic antigens (Ags) in the pig --> baboon combination. Successful down-regulation of T cell responses appeared, however, to be contingent on a tight lineage-specific expression of transferred class II molecules. The present studies were, therefore, designed to evaluate the influence of construct design and cellular environment on expression of retrovirally transferred xenogeneic class II cDNAs. Proviral genomes for pig class II SLA-DR expression, differing only at the marker neo(r) or enhanced green fluorescent protein (EGFP) gene, showed increased membrane SLA-DR density on HLA-DR(-) fibroblasts as well as HLA-DR(+), TF-1 erythroleukemia cells. More importantly, HLA-DR(+) human B cell lines, although efficiently transduced with pig DR retroviruses, exhibited unstable surface pig DR. Surface pig DR- B cells, nevertheless, stimulated autologous human T cells pre-sensitized to pig Ags, a proliferation likely occurring through presentation of class II-derived peptides. Collectively, these data suggest that surface expression of transferred class II molecules is not related to the ability of recipient cells to synthesize xenogeneic class II molecules but rather to their Ag processing capacities. 相似文献
78.
Anti-Gal alpha 1-3Gal IgM and IgG antibody levels in sera of humans and old world non-human primates
Organs transplanted from pig to primate are rejected within minutes or hours by an antibody-dependent, complement-mediated mechanism [hyperacute rejection (HAR)]. Even after depletion of anti-Galα1-3Gal (Gal) antibody (Ab), for example by extracorporeal immunoadsorption, return of natural Ab is believed to be a major factor in the initiation of acute humoral xenograft rejection. Various non-human primates are used as recipients of pig organs in experimental discordant xenotransplantation (XTx) models. However, anti-Gal IgM and IgG levels in non-human primates may differ from those in humans. Serum levels of anti-Gal IgM and IgG were measured by enzyme-linked immunosorbent assay (ELISA) in humans (n=14), chimpanzees (n=8), baboons (n=214), cynomolgus monkeys (n=29), rhesus monkeys (n=23) and Japanese monkeys (n=6). The mean level of anti-Gal IgM was significantly higher in chimpanzees than in other groups, while in rhesus monkeys it was significantly lower than in other groups, except baboons and Japanese monkeys. The mean human anti-Gal IgG level was higher than in other groups and this difference reached statistical significance except with regard to chimpanzees. The mean anti-Gal IgG level in baboons was significantly lower than that in humans, chimpanzees and cynomolgus monkeys. The measured differences in anti-Gal IgM and IgG levels may affect the kinetics of Ab removal and rate of return in different species, and thus may have relevance for translating work in non-human primate models to the clinical setting. 相似文献
79.
Xenotransplantation offers a potential solution to the shortfall in donor organs for human transplantation. This review describes the barriers to xenotransplantation and the progress that has been made towards making it a clinical reality. Data from preclinical pig-to-primate cardiac and pulmonary xenografts are highlighted. 相似文献
80.
Chong AS Ma L Yin D Shen J Blinder L XiuLong X Williams JW Byrne G Diamond LE Logan JS 《Xenotransplantation》2000,7(4):275-283
The anti-galactose-alpha1,3-galactose (Gal) antibody (Ab) response following pig-to-human transplantation is vigorous and largely resistant to currently available immunosuppression. The recent generation of GT-Ko mice provides a unique opportunity to study the immunological basis of xenograft-elicited anti-Gal Ab response in vivo, and to test the efficacy of various strategies at controlling this Ab response [1]. In this study, we compared the ability of non-depleting anti-CD4 and anti-CD8 to control rejection and antibody production in GT-Ko mice following xenograft and allograft transplantation. Hearts from baby Lewis rat or C3H mice were transplanted heterotopically into GT-Ko. Non-depleting anti-CD4 (YTS177) and anti-CD8 (YTS105) Abs were used at 1 mg/mouse, and given as four doses daily from day -2 to 1 then q.o.d. till day 21. Xenograft rejection occurred at 3 to 5 days post-transplantation in untreated GT-Ko recipients, and was histologically characterized as vascular rejection. Anti-CD4, but not anti-CD8, Ab treatment prolonged xenograft survival to 68 to 74 days and inhibited anti-Gal Ab as well as xeno-Ab production. In four of the five hearts from anti-CD4 mAbs-treated GT-Ko mice, we observed classic signs of chronic rejection, namely, thickened intima in the lumen of vessels, significant IgM deposition, fibrosis and modest mononuclear cell infiltrate of Mac-1+ macrophages and scattered T cells (CD8>CD4). Xenograft rejection in untreated, as well as anti-CD4- and anti-CD8-treated, recipients was associated with increased intragraft IL-6, IFN-gamma and IL-10 mRNA. C3H allografts were rejected in 7 to 9 days by untreated GT-Ko mice and were histologically characterized as cellular rejection. Treatment with anti-CD4 and anti-CD8 mAb resulted in graft survivals of >94.8 and 11.8 days, respectively. Anti-CD4 mAb treatment resulted in a transient inhibition of alloreactive and anti-Gal Ab production. The presence of circulating alloreactive and anti-Gal Abs at >50 days post-transplant was associated with significant IgM and IgG deposition in the graft. Yet, in the anti-CD4 mAb-treated group, the allografts showed no signs of rejection at the time of sacrifice (>100 days post-transplantation). All rejected allografts had elevated levels of intragraft IL-6, IFN-gamma and IL-10 mRNA, while the long-surviving anti-CD4-treated allografts had reduced mRNA levels of these cytokines. Collectively, our studies suggest that the elicited xeno-antibody production and anti-Gal Ab production in GT-Ko mice are CD4+ T-cell dependent. The majority of xenografts succumbed to chronic rejection, while allografts survived with minimal histological change, despite elevated levels of circulating alloAbs. Thus, immunosuppression with anti-CD4 mAb therapy induces long-term survival of allografts more effectively than to xenografts. 相似文献